期刊
THERANOSTICS
卷 12, 期 12, 页码 5504-5521出版社
IVYSPRING INT PUBL
DOI: 10.7150/thno.72258
关键词
Tau; Alzheimer?s disease; Hyperphosphorylation; Magnetic Resonance Imaging (MRI); Thioaptamer; Withaferin A; Nanoparticle; Molecular Imaging
资金
- Alzeca Biosciences, Inc.
Abnormal phosphorylation of tau is a precursor to the formation of tau fibrils in Alzheimer's disease. By using novel molecular magnetic resonance imaging (M-MRI) probes and specific aptamers, the hyperphosphorylative state can be visualized in vivo at a pre-pathological stage, enabling early-stage diagnosis of Alzheimer's disease.
The abnormal phosphorylation of tau is a necessary precursor to the formation of tau fibrils, a marker of Alzheimer's disease. We hypothesize that hyperphosphorylative conditions may result in unique cell surface markers. We identify and demonstrate the utility of such surrogate markers to identify the hyperphosphorylative state. Methods: Cell SELEX was used to identify novel thioaptamers specifically binding hyperphosphorylative cells. Cell surface vimentin was identified as a potential binding target of the aptamer. Novel molecular magnetic resonance imaging (M-MRI) probes using these aptamers and a small molecule ligand to vimentin were used for in vivo detection of this pre-pathological state. Results: In a mouse model of pathological tau, we demonstrated in vivo visualization of the hyperphosphorylative state by M-MRI, enabling the identification at a pre-pathological stage of mice that develop frank tau pathology several months later. In vivo visualization of the hyperphosphorylative state by M-MRI was further validated in a second mouse model (APP/PS1) of Alzheimer's disease again identifying the mutants at a pre-pathological stage. Conclusions: M-MRI of the hyperphosphorylative state identifies future tau pathology and could enable extremely early-stage diagnosis of Alzheimer's disease, at a pre-patholgical stage.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据